Carol Sheridan
- Oncology top 5%
- Neutropenia and Cancer Infections 3
- Cancer Cells and Metastasis 2
- Cancer Research top 5%
-
- Fibroblast Growth Factor Research 1
- Cell Biology top 10%
- Biotechnology top 10%
-
- Herpesvirus Infections and Treatments 2
-
- Immunotherapy and Immune Responses 2
-
- SARS-CoV-2 and COVID-19 Research 1
-
- Virus-based gene therapy research 1
-
- HIV Research and Treatment 1
- Co-authors
- Harikrishna NakshatriSunil BadveSanjana MehrotraPoornima Bhat‐NakshatriRobert J. GouletCharles H. TurnerHiromitsu KishimotoRobyn K. Fuchs
- Journals
- PLoS ONE (1 paper)American Journal of Obstetrics and Gynecology (1 paper)American Journal of Physiology-Endocrinology and Metabolism (1 paper)
- Partner nations
- United StatesAustraliaRussia
In The Last Decade
Carol Sheridan
14 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 645
- Cancer Research 311
- Molecular Biology 556
- Cell Biology 114
- Biotechnology 55
Countries citing papers authored by Carol Sheridan
This map shows the geographic impact of Carol Sheridan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Sheridan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Sheridan more than expected).
Fields of papers citing papers by Carol Sheridan
This network shows the impact of papers produced by Carol Sheridan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Sheridan. The network helps show where Carol Sheridan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carol Sheridan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 0 | |
| 2 | 2020 | 2 | |
| 3 | 2013 | 1 | |
| 4 | 2011 | 30 | |
| 5 | 2007 | 11 | |
| 6 | CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis | 2006 | 5 |
| 7 | CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasisbreakdown → | 2006 | 798 |
| 8 | 2006 | 16 | |
| 9 | 2006 | 94 | |
| 10 | 2005 | 131 | |
| 11 | 2004 | 12 | |
| 12 | 1996 | 5 | |
| 13 | 1994 | 10 | |
| 14 | 1989 | 1 | |
| 15 | 1987 | 3 |
About Carol Sheridan
Carol Sheridan is a scholar working on Applied Microbiology and Biotechnology, Oncology and Virology, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (3 papers), Cancer Cells and Metastasis (2 papers), Herpesvirus Infections and Treatments (2 papers), Immunotherapy and Immune Responses (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Virus-based gene therapy research (1 paper), HIV Research and Treatment (1 paper) and Fibroblast Growth Factor Research (1 paper). The work is most often cited by research in Oncology (645 citations), Cancer Research (311 citations) and Molecular Biology (556 citations). Carol Sheridan has collaborated with scholars based in United States, Australia and Russia. Frequent co-authors include Harikrishna Nakshatri, Sunil Badve, Sanjana Mehrotra, Poornima Bhat‐Nakshatri, Robert J. Goulet, Charles H. Turner, Hiromitsu Kishimoto, Robyn K. Fuchs, Miral R. Sadaria and Daryl J. Murry. Their work appears in journals such as PLoS ONE, American Journal of Obstetrics and Gynecology and American Journal of Physiology-Endocrinology and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.